本次协议转让完成后，公司控股股东将由初琳女士变更为邯郸市城欣股权投资基金合伙企业（有限合 伙），实际控制人将由初亚军先生、初琳女士变更为邯郸市人民政府国有资产监督管理委员会。 格隆汇11月25日丨新亚强(603155.SH)公布，公司控股股东、实际控制人之一初琳女士于2025年11月24 日与邯郸市城欣股权投资基金合伙企业（有限合伙）（以下简称"城欣基金"）签署了《关于新亚强硅化 学股份有限公司之股份转让协议》，约定初琳女士将其持有的94,420,253股无限售条件流通股以20.76 元/股的价格转让给城欣基金。 基于上述转让后，城欣基金持有公司94,420,253股，占公司总股本的29.90%；初琳女士持有公司 50,795,012股，占公司总股本的16.09%，一致行动人初亚军先生持有公司4,822,530股，占公司总股本的 1.53%，初琳女士及一致行动人初亚军先生合计持有公司55,617,542股，占公司总股本的17.61%。 ...

Core Viewpoint - The transfer of shares from Ms. Chu Lin, a major shareholder of Xinyaqiang, to Handan Chengxin Equity Investment Fund marks a significant change in the company's control structure, with the Handan government becoming the actual controller [1] Share Transfer Details - Ms. Chu Lin signed a share transfer agreement on November 24, 2025, to sell 94.42 million unrestricted circulating shares at a price of 20.76 yuan per share to Chengxin Fund [1] - After the transfer, Chengxin Fund will hold 94.42 million shares, accounting for 29.90% of the total share capital of the company [1] - Following the transfer, Ms. Chu Lin will hold 50.80 million shares (16.09% of total share capital), while her concerted actor, Mr. Chu Yajun, will hold 4.82 million shares (1.53% of total share capital) [1] Change in Control - The controlling shareholder will change from Ms. Chu Lin to Handan Chengxin Equity Investment Fund [1] - The actual controllers will shift from Mr. Chu Yajun and Ms. Chu Lin to the State-owned Assets Supervision and Administration Commission of Handan Municipal Government [1]

Group 1 - The controlling shareholder, Chu Lin, transferred 94.42 million unrestricted circulating shares at a price of 20.76 yuan per share to Chengxin Fund [1] - After the transfer, Chengxin Fund holds 29.90% of the company's shares, becoming the new controlling shareholder [1] - The actual controller has changed to the State-owned Assets Supervision and Administration Commission of Handan Municipal People's Government [1]

Investment Rating - The report maintains a "Recommended" rating for the chemical industry [1] Core Views - The chemical industry is expected to benefit from the ongoing "anti-involution" measures, which may lead to a significant slowdown in global chemical capacity expansion. This shift is anticipated to enhance cash flow and dividend yields for companies in the sector, transforming them from cash-consuming entities to cash-generating ones [7][27] - The report highlights the potential for domestic substitutes for Japanese semiconductor materials due to rising tensions in Sino-Japanese relations, which could accelerate the domestic market's growth in this area [6] Summary by Sections Recent Trends - The chemical industry has shown a relative performance increase of 16.1% over the past 12 months, outperforming the CSI 300 index, which increased by 11.6% [4] Key Price Movements - DMC (Dimethyl Carbonate) prices rose to 4400 CNY/ton, up 14.29% week-on-week, driven by strong demand from the electrolyte sector [14] - Lithium battery electrolyte prices increased to 27000 CNY/ton, up 8.00% week-on-week, although profit margins for manufacturers are under pressure due to rising raw material costs [14] - Diammonium phosphate prices in East China reached 3850 CNY/ton, up 5.48% week-on-week, amid rising production costs [14] Investment Opportunities - The report identifies four key opportunities in the chemical sector: 1. Low-cost expansion, focusing on companies like Wanhua Chemical and Hualu Hengsheng [9] 2. Improved industry conditions, particularly in chromium salts and phosphate rock [10] 3. New materials with high growth potential, such as electronic chemicals and aerospace materials [11] 4. High dividend yields from state-owned enterprises in the chemical sector, including China Petroleum and China National Chemical [11] Company Tracking and Earnings Forecast - The report provides a detailed earnings forecast for key companies, indicating a positive outlook for several firms in the chemical sector, with many rated as "Buy" [28]

●委托理财受托方：江苏银行股份有限公司宿迁分行。 ●本次委托理财金额：2,000.00 万元。 ●委托理财产品名称：对公人民币结构性存款 2025 年第 46 期 6 个月 D 款。 证券代码：603155 证券简称：新亚强 公告编号：2025-065 新亚强硅化学股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回 并继续进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 为提高暂时闲置资金使用效率、降低财务费用、增加股东回报，在确保不影 响募集资金投资项目建设和公司及子公司正常经营的前提下进行现金管理。 （二）资金来源 1、资金来源 本次委托理财资金来源为公司部分闲置募集资金。 ●委托理财期限：6 个月。 ●履行的审议程序：新亚强硅化学股份有限公司（以下简称"公司"）于 2025 年 4 月 9 日召开第四届董事会第三次会议、第四届监事会第三次会议，2025 年 4 月 30 日召开 2024 年年度股东大会，2025 年 10 月 29 日召开第四届董事会 第六次会议，分别审议 ...

Group 1 - The core viewpoint of the news is that Xin Ya Qiang's stock has experienced fluctuations, with a recent decline of 2.12% and a year-to-date increase of 36.12% [1] - As of November 18, the stock price is reported at 17.56 CNY per share, with a total market capitalization of 5.545 billion CNY [1] - The company has seen a net outflow of main funds amounting to 5.8692 million CNY, with significant selling pressure from large orders [1] Group 2 - For the period from January to September 2025, Xin Ya Qiang reported operating revenue of 451 million CNY, a year-on-year decrease of 19.05%, and a net profit attributable to shareholders of 78.8527 million CNY, down 20.39% year-on-year [2] - The number of shareholders has decreased by 47.19% to 20,000, while the average circulating shares per person increased by 89.35% to 15,753 shares [2] Group 3 - Since its A-share listing, Xin Ya Qiang has distributed a total of 735 million CNY in dividends, with 494 million CNY distributed over the past three years [3]

Group 1 - The organic silicon sector in A-shares experienced a significant increase, with the sector index rising nearly 3% as of the report time on November 17 [1] - The organic silicon index closed at 4639.55, up from the previous close of 4505.63, with a trading volume of 6.4 billion and a total transaction amount of 12.5 billion [2] - Key companies in the sector saw substantial gains, including Morning Light New Materials reaching a limit up, Dongyue Silicon Materials increasing over 11%, and other companies like Silicon Treasure Technology and He Sheng Silicon Industry also showing positive trends [3][4] Group 2 - A meeting for the actual controllers of the organic silicon industry is scheduled for November 18, which may establish production reduction targets [5] - Currently, most organic silicon manufacturers are in a state of suspended reporting and trading [5]

Group 1 - The core viewpoint of the news highlights the recent performance and financial metrics of Xinyaqiang, indicating a stock price increase of 40.47% year-to-date and a market capitalization of 5.722 billion yuan [1] - As of November 17, Xinyaqiang's stock price reached 18.12 yuan per share, with a trading volume of 1.42 billion yuan and a turnover rate of 2.53% [1] - The company has seen a net inflow of main funds amounting to 2.3913 million yuan, with significant buying and selling activities from large orders [1] Group 2 - For the period from January to September 2025, Xinyaqiang reported an operating income of 451 million yuan, reflecting a year-on-year decrease of 19.05%, and a net profit attributable to shareholders of 78.8527 million yuan, down 20.39% year-on-year [2] - The number of shareholders decreased by 47.19% to 20,000, while the average circulating shares per person increased by 89.35% to 15,753 shares [2] Group 3 - Since its A-share listing, Xinyaqiang has distributed a total of 735 million yuan in dividends, with 494 million yuan distributed over the past three years [3]

证券代码：603155 证券简称：新亚强 公告编号：2025-064 新亚强硅化学股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回 并继续进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●委托理财受托方：江苏银行股份有限公司宿迁分行。 ●本次委托理财金额：28,000.00 万元。 ●委托理财产品名称：对公人民币结构性存款 2025 年第 61 期 102 天 Y 款。 ●委托理财期限：102 天。 一、前次使用部分闲置募集资金进行现金管理到期赎回情况 公司于 2025 年 8 月 11 日使用部分暂时闲置募集资金 29,000.00 万元购买了 江苏银行股份有限公司对公人民币结构性存款 2025 年第 38 期 93 天 M 款产品， 具 体 内 容 详 见 公 司 于 2025 年 8 月 13 日 刊 登 于 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）上的《关于使用部分闲置募集资金进行现金管理到期赎回并 继续进行现金管理的公告》（公告编号：20 ...

Core Viewpoint - The company, XinYaqiang, is actively engaged in the production of functional additives used as protecting groups in drug synthesis, which are widely applied in the production of pharmaceuticals for various therapeutic areas including antibiotics, antiviral, antitumor, and cardiovascular diseases [1] Group 1 - The company has established long-term stable partnerships with numerous well-known pharmaceutical enterprises both domestically and internationally [1] - The functional additives are considered one of the company's core products and are currently operating at full production capacity [1]